Showing results (51-60 of 191) with videos related to
Sort By:
Pageof 20
Prion|October 12, 2010
Countering amyloid polymorphism and drug resistance with minimal drug cocktailsMartin L Duennwald, James ShorterBio-Protocol|March 4, 2021
Expression and Purification of Recombinant Skd3 (Human ClpB) Protein and Tobacco Etch Virus (TEV) Protease from <i>Escherichia coli</i>Ryan R Cupo, James ShorterRare Diseases (Austin, Tex.)|July 9, 2014
Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assemblyJames Shorter, J Paul TaylorTrends in Genetics : TIG|February 8, 2021
Open Access: A Role for p53 in c9ALS/FTD?Charlotte M Fare, James ShorterBiochimica Et Biophysica Acta|August 17, 2011
The elusive middle domain of Hsp104 and ClpB: location and functionMorgan E Desantis, James ShorterCell Cycle (Georgetown, Tex.)|April 4, 2014
Reversing deleterious protein aggregation with re-engineered protein disaggregasesMeredith E Jackrel, James ShorterDisease Models & Mechanisms|July 27, 2014
Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteinsMeredith E Jackrel, James ShorterCell|April 15, 2022
Flying under the radar: TMEM106B(120-254) fibrils break out in diverse neurodegenerative disordersKatie E Copley, James ShorterBiochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 5, 2010
Applying Hsp104 to protein-misfolding disordersShilpa Vashist, Mimi Cushman, James ShorterBio-Protocol|March 4, 2021
Karyopherin-β2 Inhibits and Reverses Aggregation and Liquid-liquid Phase Separation of the ALS/FTD-Associated Protein FUSEmma Robinson, James Shorter, Lin GuoPageof 20